MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation. Fang Y, Wang L, Wan C, Sun Y, et al. J Clin Invest 2020 Sep 29. pii: 140837. doi: 10.1172/JCI140837.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fang Y, Wang L, Wan C, Sun Y, et al. MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation. J Clin Invest 2020 Sep 29. pii: 140837. doi: 10.1172/JCI140837.
PMID: 32990678